-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

203. Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, ALL, antibodies, Biological, Coronaviruses, Follicular Lymphoma, Leukemia, SARS-CoV-2/COVID-19, viral, CLL, Diseases, Lymphoma (any), CAR-Ts, LGLL, Therapies, Genetic Disorders, MDS, B-Cell Lymphoma, Biological Processes, DLBCL, immunodeficiency, MPN, Immune Disorders, Technology and Procedures, immunotherapy, Infectious Diseases, Lymphoid Malignancies, Study Population, Clinically relevant, genomics, Myeloid Malignancies, NK cells, hematopoiesis, Proliferative disorders, immune mechanism, inflammation, stem cells, serologic tests
Monday, December 7, 2020: 7:00 AM-3:30 PM

Kathleen Jevtich1*, Susan Price, RN2*, Morgan Similuk, ScM, CGC3*, Elaine Kulm, CRNP-AC4*, Jia Yan, MS, PhD, CGC1*, Michael Setzer, ScM, CGC1*, Leila Jamal, ScM, PhD, CGC3*, Luis M Franco, MD3*, Rajarshi Ghosh, PhD1*, Magdalena Walkiewicz, PhD1* and V. Koneti Rao, MD, FRCPA5

1Centralized Sequencing Initiative, NIAID National Institutes of Health, Bethesda, MD
2Room 10/12C106, NIAID National Institutes of Health, Bethesda, MD
3NIAID National Institutes of Health, Bethesda, MD
4Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, MD
5LCIM DIR, NIAID National Institutes of Health, Bethesda, MD

Evangelos Terpos, MD, PhD1, Marianna Politou, MD2*, Theodoros N Sergentanis, MD, PhD1*, Andreas Mentis, MD3*, Vassiliki Pappa, MD4*, Maria Pagoni, MD5*, Elisavet Grouzi, MD6*, Stavroula Labropoulou, PhD3*, Ioanna Charitaki1*, Dimitra Moschandreou, MD6*, Anthi Bouhla, MD4*, Stylianos Saridakis, MD7*, Eleni Korompoki, MD1*, Chara Giatra, MD5*, Tina Bagratuni, PhD1*, Angelos Pefanis, MD8*, Sotirios Papageorgiou, MD, PhD4*, Alexandros Spyridonidis, MD, PhD9*, Anastasia Antoniadou, MD, PhD10*, Anastasia Kotanidou, MD11*, Konstantinos Syrigos, MD, PhD12*, Konstantinos Stamoulis, MD13*, George Panayiotakopoulos, MD, PhD14,15*, Sotirios Tsiodras, MD, PhD10,15*, Leonidas Alexopoulos, PhD16* and Meletios A Dimopoulos17

1Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2Hematology Laboratory Blood Bank, Aretaieion Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
3Public Health Laboratories, Hellenic Pasteur Institute, Athens, Greece
4Second Department of Internal Medicine, Hematology Unit, Attikon University General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
5Department of Hematology and Lymphomas, BMT Unit, Evangelismos General Hospital, Athens, Greece
6Department of Transfusion Service and Clinical Hemostasis, “Saint Savvas” Oncology Hospital, Athens, Greece
7Blood Bank, Evangelismos General Hospital, Athens, Greece
8Department of Internal Medicine, Sotiria General Hospital of Chest Diseases, Athens, Greece
9BMT Unit, University Hospital of Patras, University of Patras, School of Medicine, Patras, Greece
10Fourth Department of Internal Medicine, Attikon University General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
11First Department of Critical Care Medicine and Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
12Third Department of Medicine, Oncology Unit, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
13Hellenic National Blood Transfusion Center, Athens, Greece
14Pharmacology Laboratory, University of Patras, School of Medicine, Patras, Greece
15National Public Health Organization, Athens, Greece
16Biomedical Systems Laboratory, National Technical University of Athens, Athens, Greece
17Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece

Kenta Yamamoto1*, Robert Blum1* and Dan S Kaufman, MD, PhD2

1Department of Medicine, Division of Regenerative Medicine, University of California- San Diego, La Jolla, CA
2Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA

Allyson M. Flower, MD1*, Rachel Friedmann, DO2*, Janet Ayello, MS, MT(ASCP)1*, Olivia Rigot, PhD1*, Lauren Harrison, RN, MSN1*, Erin Morris, RN, BSN1*, Meghan Sturhahn, RN, MSN3*, Elana Maryamchik, MD4*, Yongping Wang, MD5*, Lynn O'Donnell, PhD6*, Rolla Abu-Arja, MD7*, Dean Anthony Lee, MD, PhD8, Julie-An Talano, MD9, Bryon Johnson, PhD10, Nancy Bunin, MD5 and Mitchell S Cairo, MD1

1Pediatrics, New York Medical College, Valhalla, NY
2Pediatrics, Westchester Medical Center, Valhalla, NY
3Pediatrics, New York Medical College, Armonk, NY
4Children's Hosptial of Philadelphia, Phiadelphia, PA
5Children's Hospital of Philadelphia, Philadelphia, PA
6Pediatrics, Ohio State University, Columbus, OH
7Pediatrics, Nationwide Children’s Hospital, Columbus, OH
8Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH
9Medical College of Wisconsin, Milwaukee, WI
10Division of Hematology, Oncology and Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

Chiara Cattaneo1*, Valeria Cancelli, MD1*, Chiara Pagani, MD1*, Alessandra Tucci, MD1*, Giuseppe Rossi, MD1, Luisa Imberti, MD2*, Alessandra Sottini, BS2*, Kerry Dobbs, BS3*, Elana Shaw, BS3*, Luigi D. Notarangelo, MD3*, Jeffrey Cohen, MD4* and Peter Burbelo, PhD5*

1Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
2CREA (AIL Center for Hemato-Oncologic Research), Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
3Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
5National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD

Ling Tian, PhD1*, Monique Chavez, BS2 and Lukas D Wartman, MD3

1Department of Medicine, Division of Oncology, Washington University School of Medicine, SAINT LOUIS, MO
2Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO
3Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Namita Kumari, PhD1*, Marina Jerebtsova, PhD2, Songping Wang3*, Sharmin Diaz, NP4* and Sergei Nekhai, PhD5,6

1Medicine, Sickle Cell Center, Howard University, Washington, DC
2Department of Microbiology, Howard University, McLean, VA
3Center for Sickle Cell Disease, Howard University, Washington DC, DC
4Medicine, Howard University, Washington DC, DC
5Department of Medicine, Howard University, Washington, DC
6Center for Sickle Cell Disease and Department of Medicine, Howard University, Washington, DC

*signifies non-member of ASH